Mesna
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
365 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Lymphoma | D008223 | — | C85.9 | 25 | 58 | 9 | 1 | 6 | 86 |
| Multiple myeloma | D009101 | — | C90.0 | 8 | 12 | 2 | 1 | — | 19 |
| Germ cell and embryonal neoplasms | D009373 | — | — | 4 | 6 | 1 | 1 | 3 | 13 |
| Plasma cell neoplasms | D054219 | — | — | 3 | 7 | 2 | 1 | — | 11 |
| Sclerosis | D012598 | — | — | 4 | 4 | 3 | 1 | — | 10 |
| Systemic scleroderma | D012595 | EFO_0000717 | M34 | 3 | 3 | 3 | 1 | — | 8 |
| Diffuse scleroderma | D045743 | EFO_0000404 | — | 3 | 3 | 3 | 1 | — | 8 |
| T-cell lymphoma | D016399 | — | — | 1 | 6 | — | 1 | — | 7 |
| Medulloblastoma | D008527 | — | — | 2 | 2 | 1 | 1 | 1 | 7 |
| T-cell lymphoma peripheral | D016411 | — | — | 1 | 4 | — | 1 | — | 5 |
Show 5 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Leukemia | D007938 | — | C95 | 26 | 47 | 15 | — | 4 | 79 |
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 14 | 35 | 13 | — | 1 | 55 |
| Lymphoid leukemia | D007945 | — | C91 | 9 | 25 | 13 | — | — | 40 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 12 | 27 | 4 | — | 3 | 37 |
| Sarcoma | D012509 | — | — | 12 | 17 | 7 | — | 4 | 35 |
| Neoplasms | D009369 | — | C80 | 21 | 17 | 1 | — | 3 | 35 |
| Myelodysplastic syndromes | D009190 | — | D46 | 10 | 17 | 1 | — | 2 | 25 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 9 | 16 | 1 | — | 1 | 24 |
| Myeloid leukemia | D007951 | — | C92 | 7 | 15 | 1 | — | — | 20 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 8 | 15 | 2 | — | — | 19 |
Show 44 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Melanoma | D008545 | — | — | 10 | 15 | — | — | 1 | 23 |
| Hematologic neoplasms | D019337 | — | — | 13 | 15 | — | — | 1 | 21 |
| Neoplasm metastasis | D009362 | EFO_0009708 | — | 12 | 10 | — | — | 1 | 17 |
| Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | 2 | 12 | — | — | — | 12 |
| B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 2 | 9 | — | — | — | 9 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 4 | 6 | — | — | — | 8 |
| Primary myelofibrosis | D055728 | — | D47.4 | 3 | 5 | — | — | — | 8 |
| Myelomonocytic leukemia juvenile | D054429 | — | C93.3 | 3 | 6 | — | — | — | 7 |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 5 | 6 | — | — | — | 7 |
| Carcinoma | D002277 | — | C80.0 | 2 | 4 | — | — | — | 6 |
Show 138 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Rhabdoid tumor | D018335 | — | — | 2 | — | — | — | 1 | 3 |
| Wilms tumor | D009396 | EFO_0000212 | — | 2 | — | — | — | — | 2 |
| Triple negative breast neoplasms | D064726 | — | — | 1 | — | — | — | — | 1 |
| Fallopian tube neoplasms | D005185 | — | — | 1 | — | — | — | — | 1 |
| Cutaneous malignant melanoma | D000096142 | — | — | 1 | — | — | — | — | 1 |
| Blastic plasmacytoid dendritic cell neoplasm | D000099067 | — | C86.4 | 1 | — | — | — | — | 1 |
| Ganglioneuroblastoma | D018305 | — | — | 1 | — | — | — | — | 1 |
| Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | 1 | — | — | — | — | 1 |
| Vasculitis | D014657 | EFO_0006803 | M31 | 1 | — | — | — | — | 1 |
| Myositis | D009220 | EFO_0000783 | G72.49 | 1 | — | — | — | — | 1 |
Show 15 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Vomiting | D014839 | — | R11.1 | — | — | — | — | 2 | 2 |
| Nausea | D009325 | — | R11.0 | — | — | — | — | 2 | 2 |
| Drug-related side effects and adverse reactions | D064420 | — | T88.7 | — | — | — | — | 1 | 1 |
| Aggression | D000374 | EFO_0003015 | — | — | — | — | — | 1 | 1 |
| Histiocytosis | D015614 | HP_0100727 | — | — | — | — | — | 1 | 1 |
| Langerhans-cell histiocytosis | D006646 | — | C96.6 | — | — | — | — | 1 | 1 |
| Wiskott-aldrich syndrome | D014923 | EFO_0003903 | D82.0 | — | — | — | — | 1 | 1 |
| Severe combined immunodeficiency | D016511 | — | D81.0 | — | — | — | — | 1 | 1 |
| Hemophagocytic lymphohistiocytosis | D051359 | — | D76.1 | — | — | — | — | 1 | 1 |
| Chronic granulomatous disease | D006105 | EFO_0000338 | D71 | — | — | — | — | 1 | 1 |
Show 15 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
6,660 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use